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RNA interference (RNAi) has been extensively used
to identify host factors affecting virus infection but
requires exogenous delivery of short interfering
RNAs (siRNAs), thus limiting the technique to non-
physiological infection models and a single defined
cell type. We report an alternative screening
approach using siRNA delivery via infection with a
replication-competent RNA virus. In this system, nat-
ural selection, defined by siRNA production, permits
the identification of host restriction factors through
virus enrichment during a physiological infection.
We validate this approach with a large-scale siRNA
screen in the context of an in vivo alphavirus infec-
tion. Monitoring virus evolution across four indepen-
dent screens identified two categories of enriched
siRNAs: specific effectors of the direct antiviral
arsenal and host factors that indirectly dampened
the overall antiviral response. These results suggest
that pathogenicity may be defined by the ability of
the virus to antagonize broad cellular responses
and specific antiviral factors.
INTRODUCTION
The cellular response to virus infection in vertebrates relies on an
extensive signaling network that culminates in the production of
antiviral cytokines and upregulation of hundreds of antiviral gene
products (tenOever, 2013). With respect to RNA viruses, cellular
detection is the result of RNA structures foreign to the cell
including double-stranded RNA and RNA with exposed 50
triphosphates (Kolakofsky et al., 2012). Detection of these
genetic structures, commonly referred to as pathogen-associ-
ated molecular patterns (PAMPs), is mediated by pathogen
recognition receptors (PRRs), such as RIG-I and MDA5 (Loo
and Gale, 2011; Takeuchi and Akira, 2008). PRR engagement re-346 Cell Host & Microbe 14, 346–356, September 11, 2013 ª2013 Elsults in recruitment to the mitochondria and subsequent assem-
bly of many host factors including the mitochondrial antiviral
signaling protein (MAVS, also called IPS-1, VISA, and Cardiff),
as well as a number of Traf family members (McWhirter et al.,
2005). MAVS engagement coordinates the activation of NF-kB
and IRFs through the IKK and IKK-related kinases, respectively,
resulting in the assembly of the IFNb (Ifnb) enhancesome and
subsequent gene induction (McWhirter et al., 2005). IFNb, a
type I IFN (IFN-I), leads to upregulation of hundreds of IFN-stim-
ulated genes (ISGs), which together cooperate to slow virus
replication (Li et al., 2013; Schoggins et al., 2011).
Many ISGs and virus host factors have been identified as a
result of RNAi screening. High-throughput screens have been
used to investigate a myriad of host factors that impact the repli-
cation capacity of influenza A virus (IAV), dengue virus, hepatitis
C virus (HCV), West Nile virus (WNV), and human immunodefi-
ciency virus (HIV) (Brass et al., 2008; Ko¨nig et al., 2008, 2010;
Krishnan et al., 2008; Li et al., 2009; Sessions et al., 2009). These
screens have yielded valuable insights into virus-host interac-
tions, yet they all demand the use of in vitro cell cultures and
an indirect measure of virus output (i.e., luciferase or cell surface
staining). Consequently, efforts are being undertaken to study in-
fections in their physiological context by monitoring genomic
polymorphisms between outbred mice and correlating these to
virus susceptibility (Ferris et al., 2013). In an effort to expand
upon the findings of traditional in vitro siRNA approaches, we
sought to adapt this screening platform to an in vivo infection,
thereby eliminating the need for a transformed cell line and allow-
ing the direct measure of viral output. To this end, we combined
the silencing potential of whole-genome siRNA libraries with
the capacity of viruses to produce functional microRNAs
(miRNAs).
The discovery that small RNAs (sRNAs) between 19 and 22 nu-
cleotides (nt) in length have the capacity to silence host tran-
scripts ushered in a new era for molecular biology (Bartel,
2004). Generally referred to as RNA interference (RNAi), the
silencing potential of sRNAs is largely an attribute to the amount
of complementarity between sRNA and mRNA (Bartel, 2004).
Endogenous miRNA posttranscriptional silencing (PTS) typically
results in ‘‘fine-tuning’’ of target expression with changes of lesssevier Inc.
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ever, the silencing capacity of miRNAs can match the ability of
siRNAs to enzymatically cleave transcripts, if either the target
transcript or the miRNA itself is modified to achieve perfect
complementarity (Zeng et al., 2002). Given the silencing potential
of sRNAs, numerous viruses have been shown to utilize this form
of posttranscriptional regulation to create a more favorable repli-
cation environment (Cullen, 2011). Perhaps not surprisingly,
virus utilization of miRNAs has been limited to those that repli-
cate in the nucleus and persist for extended periods of time
(Cullen, 2011). Furthermore, despite extensive sequencing
efforts, no RNA virus, void of a DNA intermediate, has been
found to encode a canonical miRNA (Kincaid et al., 2012; Para-
meswaran et al., 2010; Perez et al., 2009; Pfeffer et al., 2004;
tenOever, 2013). However, lack of endogenous evidence for
RNA virus-mediated miRNA production is not indicative of an
inherent constraint. This is perhaps best exemplified by the
fact that we and others, have demonstrated that RNA viruses,
regardless of genome polarity or site of replication, can be engi-
neered to generate such products (Langlois et al., 2012; Rouha
et al., 2010; Shapiro et al., 2010, 2012; Varble et al., 2010).
Here we describe an RNAi-based approach to identify interac-
tions between virus and host that impact overall replication in the
context of an in vivo infection. This is achieved by enabling siRNA
delivery through a replication-competent alphavirus. To this end,
we generated a Sindbis-based library of viruses that are identical
at a protein level, but each virion encodes a unique siRNA
capable of silencing a single open reading frame (ORF). These li-
braries were subjected to a selective pressure to parse out those
host factors that enhance replication. Screening both in vitro and
in vivo corroborated a number of known antiviral host factors but
also identified ORFs that, when silenced, resulted in enhanced
virus replication. These data suggest that virus replication and
pathogenicity may be the product of more than the known anti-
viral host genes and provides insights into other factors that may
be the target of viral antagonists.
RESULTS
Sindbis Virus-Mediated Silencing of GFP
With the knowledge that RNA viruses have the capacity to elicit
PTS, we utilized a miR-30-based whole-genome-targeting li-
brary (Silva et al., 2005) to probe for virus-host interactions using
the pathogen as the siRNA deliverymechanism. Given that a nat-
ural infection results in viral quasispecies that provide the ability
to adapt to the host response (Vignuzzi et al., 2006), we reasoned
that a library of engineered viruses, each equipped to silence one
host factor, may mimic this selection process. To this end, we
generated a large cohort of attenuated and mouse-adapted
Sindbis viruses (SINV), each designed to produce an artificial
miRNA (amiRNA) and monitored selection in vivo (Figure S1A).
To demonstrate the capacity of SINV to act as a platform for
amiRNA delivery, we designed a collection of five unique hairpins
targeting enhanced green fluorescent protein (GFP). Accurate
processing and PTS of these amiRNAs was confirmed by small
RNA northern blot and western blot, respectively (Figures S1B
and S1C). These data demonstrate four of the five hairpins effec-
tive in silencing GFP, with two hairpins showing complete knock-
down (Figure S1C). To ascertain whether incorporation of a GFPCell Host & MamiRNA conferred silencing activity onto SINV, amiRNA-GFP122,
which was designed to conform to the structure of miR-124 (Fig-
ure 1A), was inserted into the recombinant SINV. As previously
described (Shapiro et al., 2010, 2012), despite the cytoplasmic
replication of SINV, amiRNA-GFP122 demonstrated accurate
processing and robust expression at every time point evaluated
following SINV-amiRNA-GFP infection (Figure 1B). More impor-
tantly, the capacity to generate the amiRNA also enabled the
virus to silence GFP expression in the context of infection
(Figure 1C).
Targeting ISGs In Vitro Provides Enhanced Virus
Replication
Given the capacity to confer GFP silencing potential onto SINV,
we next sought to determine whether silencing of an ISG could
enhance overall replication. To this end, we designed an amiRNA
library to a subset of ISGs, targeting each ORF with two distinct
hairpins (Table S1). These amiRNAs were individually generated
following the same strategy as SINV-amiRNA-GFP (Figure 1A).
Quadruplicate passaging in vitro showed evidence for positive
selection of viruses targeting: IKKb (Ikbkb) and RIG-I (Ddx58)
(Figure S2A). Among the enriched amiRNAs, identification of
two independent siRNAs silencing RIG-I prompted us to charac-
terize aDdx58-targeting virus further (Figure 2A). Given that RIG-
I has not been directly implicated in SINV detection, we first used
an independent siRNA to silence this factor in vitro (Figure S2B).
In agreement with data implicating RIG-I sensing for Chikungu-
nya virus, a related alphavirus (Schilte et al., 2010), we found a
significant enhancement of virus replication as a result of
in vitro RIG-I silencing (Figure S2C). Furthermore, we compared
virus titers in wild-type and Ddx58/ fibroblasts and corrobo-
rated the RNAi data, finding virus levels were elevated by more
than one log in the absence of this PRR (Figure S2D). Following
this observation, we engineered SINV to express an amiRNA
designed to silence murine RIG-I (SINV-amiRNA-RIG-I) and
compared this to a control SINV strain encoding a nonspecific
amiRNA (SINV-amiRNA-Ctrl). Cell culture infections comparing
the control virus (SINV-Ctrl) to SINV-amiRNA-RIG-I demon-
strated accurate processing of the amiRNA and the capacity to
diminish RIG-I protein expression (Figures S2E and 2B). Not
surprisingly, the amiRNA-RIG-I also conferred a replicative
advantage to this attenuated SINV strain, as virus levels were
an order of magnitude higher compared to a matched control
virus (SINV-Ctrl) (Figure 2C). Improved levels of replication
were the direct result of amiRNA-mediated targeting, as this
phenotype was lost in cells lacking the capacity to generate
miRNAs due to Dicer deficiency (Figures S2F and S2G).
Small RNA-Mediated Natural Selection In Vivo
Given the replicative advantage conferred onto SINV through
use of an encoded amiRNA, we utilized a small collection of
viruses containing unique hairpins to determine whether natural
selection would parse out advantageous noncoding RNAs in the
context of an in vivo infection and ascertain the timing of enrich-
ment. This initial SINV library was composed of approximately
4,000 unique hairpins, each designed to target a murine ORF
(Silva et al., 2005). Population infection experiments, followed
by small RNA cloning and deep sequencing analysis, demon-
strated approximately 75% of the amiRNAs were processed asicrobe 14, 346–356, September 11, 2013 ª2013 Elsevier Inc. 347
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Figure 2. SINV Replication Can Be Modulated by amiRNA Expres-
sion
(A) Schematic depicting the mmu-miR-124-2 hairpins modified to target RIG-I
selected for during in vitro passaging.
(B) Western blot analysis of whole-cell extract derived from murine embryonic
fibroblasts (MEFs) infected with SINV-RIG-I or -Ctrl (moi = 0.01). Blots depict
RIG-I, SINV capsid, and actin.
(C) Multicycle growth curve of viruses in (B). Data are presented as plaque-
forming units per ml (pfu/ml). One-tailed Student’s t test was used to calculate
the p value, *p < 0.05, **p < 0.005. Error bars indicate ± SEM. LOD = limit of
detection. See also Figure S2 and Table S1.
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Figure 1. Functional amiRNA Production from Sindbis Virus
(A) Schematic depicting the native mmu-miR-124-2 hairpin (top) followed by a
modified hairpin designed to target GFP (bottom).
(B) Small RNA northern blot of RNA derived from BHK cells infected with SINV
(moi = 1) expressing an amiRNA designed to silence GFP (SINV-amiRNA-
GFP). Blots were probed for the amiRNA and U6 at indicated time points.
(C) Western blot analysis of whole-cell extract derived from SINV-Ctrl and
SINV-amiRNA-GFP-infected BHK cells (moi = 2) expressing pEGFP. Blots
depict GFP, SINV capsid, and actin. See also Figure S1.
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348 Cell Host & Microbe 14, 346–356, September 11, 2013 ª2013 Elpredicted (Figure S3). This viral population was subsequently
administered into mice via footpad injection, and virus was
isolated from total spleen 48 hr postinfection. Composition of
amiRNAs present in viral populations was monitored through
deep sequencing and revealed a clear enrichment of certain hair-
pins by the third mouse passage (Figure 3A). To determine if this
enrichment was the direct result of the hairpin or a consequence
of unrelated mutations elsewhere in the viral genome, we em-
ployed a genetic reset between passages three and four. The
reset was accomplished by recloning the hairpins from passage
three into the original viral genome, thereby ensuring no othersevier Inc.
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Figure 3. Monitored Enrichment of amiRNA during In Vivo Passages
(A) Matlab plot representing amiRNA viral hairpins present in the overall viral or plasmid populations. Each color depicts a unique amiRNA whose relative
proportion corresponds to its abundance in the virus population at indicated passages (P). ‘‘Plasmid’’ depicts the hairpin diversity present in the SINV cDNA
clones; ‘‘Virus’’ depicts hairpins present in the SINV amiRNA library, and ‘‘P1-P4’’ depicts hairpins identified in the spleen following each in vivo passage. Mice
were infected with 5 3 106 plaque forming units (pfu) via footpad injection.
(B) Small RNA northern blot derived from cells infected with a recombinant Sindbis virus (rSINV) (moi = 1.0) encoding the most enriched amiRNA from (A). Blot
analyzed for amiRNA and U6 expression.
(C) Virus titers derived from the spleens of mice infected via footpad injection with 5 3 105 pfu of either SINV-Ctrl or SINV-amiRNA and collected 48 hr post-
infection. One-tailed Mann-Whitney U-test was used to calculate p value, n = 7, *p < 0.05. LOD = limit of detection. See also Figure S3.
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In Vivo RNAi Identifies Virus Replication Factorsmutations were present for the final passage. Upon readminis-
tering these three stains to naivemice, we found theymaintained
the same population dynamic, suggesting fitness enhancement
correlatedwith amiRNA expression rather than unrelated genetic
mutations (Figure 3A). Additionally, we determined optimal
selection with three passages, as clear enrichment trends could
be observed at this point. To further corroborate this idea, we
again performed a genetic reset and generated a recombinant
SINV expressing the most enriched amiRNA identified in this
small screen (predicted to target USP32, a known ISG). Northern
blot of cells infected with the recombinant virus demonstrated
accurate processing and robust expression of this small RNA
(Figure 3B). Furthermore, we compared virus growth of this
amiRNA-containing-virus to a SINV encoding a nonspecific
amiRNA (Figure 3C). As expected, incorporation of the amiRNACell Host & Mresulted in titers that were approximately one log higher than the
control virus at 48 hr after in vivo infection (Figures 3C).
Large-Scale Genome Screening In Vivo to Identify Host/
Virus Interactions
In an effort to conduct a more comprehensive, unbiased in vivo
screen, we expanded the amiRNA virus library to approximately
10,000 unique hairpins and generated a second library of
random barcodes that would not exert a selective advantage
(Figures 4A and 4B). Using these two distinct libraries, we per-
formed individual quadruplicate in vivo passaging sets and
monitored the resulting eight populations by deep sequencing.
Data were collected using four mice per passage per library,
across three 48 hr infections. Barcoded or hairpin reads were
consolidated and those viruses that represented at least 2% oficrobe 14, 346–356, September 11, 2013 ª2013 Elsevier Inc. 349
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Figure 4. amiRNAs Confer a Reproducible
Selection Advantage
(A and B) Venn diagrams depicting overlap of
either barcoded (A) or amiRNA-expressing (B)
viruses from four parallel in vivo screens. Shown
are the number of viruses that make up more than
2% of the final viral population in each screen as
determined by deep sequencing.
(C) Table of the number of clones found in at least
1, 2, 3, or 4 of the sets described in (A) aswell as the
proportion of each clone with respect to the total
number of viruses present in the final passage.
(D) Same as (C) with respect to sets described in
(B). See also Figure S4 and Table S2.
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demonstrated that only 0.5% of barcoded viruses could be iden-
tified as present in two sets with no barcoded strains being
isolated in three or more (Figure 4C). In contrast, amiRNA-con-
taining viruses showed a 16-fold enrichment for strains being
found in two or more sets (Figure 4D and Table S2). Additionally,
we could identify strains that were present in three or more in-
dependent sets. Not surprisingly, large cohorts of enriched
amiRNAs targeted known ISGs and were annotated as virus
response genes (Figure 5A). The only other two major categories
of functionally grouped genes that demonstrated greater than 5-
fold enrichment by passage three silenced factors involved in
cellular homeostatis and general transcription (Figure 5A and
Table S3).
Enriched amiRNAs Demonstrate Targeting and Alter
Host Capacity to Limit Virus Replication
To independently corroborate the results of this in vivo screen,
we determined the silencing potential of candidate amiRNAs
that were identified in at least two independent sets. For each
amiRNA, small RNA processing and expression by northern
blot could be verified from both plasmid (Figure S4A) and SINV
infection (Figures S4B and S4C). Furthermore, these same
amiRNAs could be validated for silencing potential, and all but
one resulted in a significant increase in virus titer when silenced
with independently verified siRNAs (Figures S4D–S4J). To define
the host factors that provided the most robust replicative advan-
tage to the virus, we focused on the two hairpins that were en-
riched in three or more independent screens. Interestingly,
both of these amiRNAs are predicted to target transcription
factors implicated in self-renewal (Hu et al., 2009): Zinc finger
protein X (amiRNA-Zfx) and the MAX gene-associated protein
(amiRNA-Mga). Strikingly, Zfx and a factor sharing significant ho-
mology with Mga (Hurlin et al., 1999), Myc, have been demon-
strated to share similar transcription factor occupancies involved
in the regulation of genes related to cell cycle, cell death, and
cancer (Chen et al., 2008; Hu et al., 2009). Notably, the subset
of genes targeted by Zfx and Myc were found to include Stat1
(Chen et al., 2008; Hu et al., 2009), an essential transcription fac-
tor in the antiviral response (Levy and Darnell, 2002). Given the350 Cell Host & Microbe 14, 346–356, September 11, 2013 ª2013 Elsevier Inc.predominant selection for amiRNAs tar-
geting genes involved in transcription
(Figure 5A) and the apparent overlap be-
tween Zfx and Mga, we sought to furthercharacterize how loss of either of these factors might impact the
capacity for cells to limit virus replication.
Reduced Expression of Zfx and Mga Compromise the
Cellular Host Antiviral Defense
To ensure that silencing of Mga could be directly implicated in
conferring increased viral fitness, we independently targeted
this host factor with an siRNA complementary to a unique re-
gion of the ORF (Figure S5A). Loss of Mga, independent of
an amiRNA, produced a comparable phenotype, allowing
SINV to replicate to one order of magnitude higher as
compared to control siRNA (Figure S5B). In agreement with
the depletion studies, we observed a corresponding decrease
in viral replication following overexpression of Mga (Figure 5B).
Moreover, loss of ISGs in the absence of Mga suggests that
this transcription factor coordinates a critical role in the cellular
response to virus infection (Figure 5C). This role for Mga was
not restricted to SINV as we additionally observed comparable
results upon infection with an attenuated influenza A virus,
stimulation with double stranded RNA, or IFN-I treatment (Fig-
ure S5C). To corroborate Zfx’s role in the antiviral response, we
utilized primary fibroblasts from Zfx conditional knockout mice
(Galan-Caridad et al., 2007). Comparable to the loss of Mga,
genetic disruption of Zfx resulted in a 1.5 log increase in viral
replication (Figure 5D). Additionally, loss of Zfx correlated
with a dramatic reduction in ISGs, similar to the phenotype
following Mga knockdown (Figure 5E). Taken together, these
results suggest that Mga and Zfx are required to maintain a
transcriptome capable of eliciting an effective response to virus
replication.
In Vivo Screening Selects for Viruses Capable of
Modulating Diverse Signaling Networks
To better understand why two relatively unknown factors were
selected for their capacity to enhance replication, we investi-
gated how each of the ORFs related to known antiviral
pathways. To this end, we first investigated the transcriptional
activity of the Ifnb gene in response to SINV following ctrl,
Mga, or Zfx targeting (Figures S6A and S6B). These data
revealed that loss of either Mga or Zfx resulted in a significant
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D E
A P1 P2 P3 response to virus
transcription 
homeostatic
process
Figure 5. Mga and Zfx Aid in Coordinating
the Antiviral Response
(A) Pie charts depicting gene function categories
of predicted targets for every virus present at
0.01% or greater of the total populations in P1, P2,
and P3.
(B) Multicycle growth curve of SINV performed in
murine Hepa1.6 cells (moi = 0.01) and transfected
with GFP or Mga expression plasmids.
(C) Western blot analysis of whole-cell extract
derived from human lung bronchial epithelial cells
(A549) treated with scrambled (Scbl) or Mga-
targeting siRNAs and infected (48 hr post-
transfection) with SINV (moi 0.1) and harvested.
Blots depict RIG-I, STAT1, SINV capsid, and actin
at the indicated time points.
(D) Multicycle growth curve of SINV-infected (moi
0.1) primary fibroblasts (Zfx fl/fl) treated with
adeno-GFP or adeno-GFP/Cre and harvested at
indicated time points.
(E) Western blot analysis of whole-cell extract
derived from primary fibroblasts from (D). Blots
depict Zfx, STAT1, SINV capsid, and actin. One-
tailed Student’s t test was used to calculate the p
value and error bars denote ± SEM, *p < 0.05, **p <
0.005, and ***p < 0.0005. See also Figure S5 and
Table S3.
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loss of STAT1 at both the protein and RNA level (Figures 5C,
5E, and 6B). To further elucidate the molecular mechanism
responsible for loss of IFNb, we determined whether the IFN-
I-dependent transcriptional induction of Stat1 was impacted
by the loss of Mga and/or Zfx (Figure 6C). These data found
that while the consequence of gene disruption resulted in com-
parable viral phenotypes and loss of IFN-I, the interruption of
antiviral signaling was occurring at different stages in the
signaling pathway. IFN-I-mediated upregulation of Stat1 was
compromised only following knockdown of Mga (Figure 6C).
These data implicate Mga in maintaining the capacity to
respond to IFN-I. To determine the mechanism by which vi-
rus-induced Ifnb and Stat1 is lost following Zfx knockdown,
we analyzed NF-kB activity following TNF-a treatment (Fig-
ure 6D). These data implicated Zfx, but not Mga, in this cellular
pathway. To better define the impact from loss of Mga and Zfx
on the cellular transcriptome, we performed mRNA-Seq (Fig-
ures 6E and 6F and S6C and S6D). In agreement with the
observed phenotype, these data demonstrated a dramatic
decrease of the host machinery required for IFN-I and virus-
induced signaling, suggesting this to be the cause for subse-
quent loss of IFN-I and ISG production (Table S4). Interestingly,
loss of Zfx resulted in a dramatic loss of IKKb (Ikbkb), the same
virus-activated gene selected for in our in vitro studies (Fig-
ure S2A). Furthermore, siRNA treatment of Mga resulted in
diminished levels of Irf9, Stat2, Ifnar1, Ifnar2, and perhaps
most importantly, Irf7. It is also noteworthy that loss of ZfxCell Host & Microbe 14, 346–356, Seand Mga both resulted in a significant
reduction in RIG-I, also in agreement
with our in vitro screens. Taken together,
these data suggest that virus fitness maybe defined by the ability of the pathogen to antagonize broad
cellular responses rather than specific antiviral factors.
DISCUSSION
Here we describe a means by which to identify host factors
required to maintain low levels of virus infection in the context
of an in vivo model. Following the discovery that RNA viruses
could be engineered to express miRNAs (Langlois et al., 2012;
Rouha et al., 2010; Shapiro et al., 2010, 2012; Varble et al.,
2010), we decided to exploit this activity and use it to perform
siRNA screening in the hopes that it would aid in identifying
aspects that control in vivo virus replication. This approach is
unique compared to present strategies aimed at identifying
similar interactions between host and pathogen in that standard
siRNA screens demand nonphysiological infection models as
they rely on cell culture. By enabling siRNA delivery through repli-
cation-competent RNA viruses, we can harness natural selection
through siRNA production, allowing evolution to parse out those
factors that are important in restricting natural infection regard-
less of cell type. Here we describe three such screens. First,
we performed an in vitro screen to ascertain whether targeting vi-
rus-activated genes can enhance virus replication. This work
identified RIG-I and IKKb as important modulators of virus repli-
cation in cell culture. Following this proof-of-principle study, we
investigated whether we could observe selection and enhanced
replication in vivo using a significantly larger amiRNA library.
Monitoring virus populations from this study revealed thatptember 11, 2013 ª2013 Elsevier Inc. 351
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Figure 6. Zfx and Mga Perform Distinct Roles in Antiviral Signaling
(A) Quantitative real-time PCR (qPCR) analyses of RNA derived from A549 cells treated with scrambled (Scbl), Zfx, or Mga-targeting siRNAs and infected with
SINV (moi = 2.0) and analyzed for Ifnb transcription.
(B) Same as (A) for Stat1.
(C) qPCR analysis of IFNb-treated uninfected cells described in (A) and analyzed for Stat1.
(D) qPCR analysis of TNF-a-treated uninfected cells described in (A) and analyzed for Mmp-9. For all qPCR, Student’s t test was used to calculate the p value and
error bars denote ± SEM, *p < 0.05 and **p < 0.005.
(E) RNA-seq analysis on RNA extracted from primary fibroblasts (Zfx fl/fl) treated with adeno-GFP or adeno-GFP/Cre. Heatmap depicts fold change of genes as
compared to adeno-GFP treatment. Genes were clustered into groups of IFN-stimulated genes (ISGs), genes responsible for IFN induction, IFN signaling, and
housekeeping genes.
(F) RNA extracted from primary fibroblasts (E) treated with adeno-GFP, dsRNA, and Mga siRNA. Standard RNA-seq analysis was performed and analyzed as in
(E). See also Figure S6 and Table S4.
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also identified genes previously implicated in the cellular
response to virus infection. Last, we performed a large-scale
screen to investigate selection in an unbiased manner. This
work identified a combination of ISGs as well as factors involved
in host transcription, including Zfx andMga. Interestingly, loss of
these factors resulted in a dramatic remodeling of the transcip-
tome and a loss ofmany antiviral genes including RIG-I and IKKb.
It is noteworthy that this screen has a number of parameters
that must be considered when evaluating the data. First, as the
output of this screen is based on the emergence of dominant
strains, it is biased toward the identification of siRNAs that pro-
vide an advantage following silencing only within an infected cell.
Furthermore, these dynamics change with time, for example, if
the IFN response has been induced, there is little advantage to
silence PRRs. Moreover, as the characteristics of the hairpin
population change over time, the relative fitness conferred by a
hairpin may also fluctuate. In contrast, neutral hairpins, or those
that cease to provide a benefit, should undergo counter selec-
tion. As SINV-mediated amiRNA production results in a low level
of self-targeting (Shapiro et al., 2010), only those providing a net
positive effect on viral fitness will be maintained throughout sub-
sequent passages. In addition to the bias for viral effectors, cur-
rent gaps in knowledge of siRNA silencing, coupled with the
acute time frame of the viral infection, also impose some inherent
constraints on this technological platform. For example, suc-
cessful generation of an amiRNA does not always equate to
significant knockdown of the target protein (Figure S1C).
Conversely, off-target effects can complicate the function of a
selected amiRNA, although this activity was not overtly apparent
given our capacity to validate our top hits with knockout cells and
independent siRNA experiments. In addition to siRNA dynamics,
should protein half-life significantly exceed the viral life cycle, no
advantage would be gained from cognate mRNA silencing.
Factors such as these prevent absolute targeting of the tran-
scriptome. Furthermore, it should be noted that the host factors
identified by such a selection processwould be influenced by the
type of screen performed. For example, our proof-of-concept
study here focused on increased virus titers from cell culture
and splenic samples. However, as alphaviruses are neurotropic
and elicit a unique immune response in the CNS (Griffin, 2003),
intranasal inoculation followed by virus isolation in the brain
may enrich for factors associated with crossing the blood-brain
barrier in addition to a unique subset of host factors that enhance
general replication. The capacity to perform such a screen with
the same amiRNA library used in this study also illustrates the
flexible nature of this technology to parse out an expansive list
of virus/host interactions that are specific to a particular variable
and/or pathogen.
Implicating host factors that contribute to the severity of a virus
disease is essential in this new era of personal genomics (Everitt
et al., 2012). In the context of an in vivo virus infection, our RNAi
screen revealed two transcription factors as being important
regulators of the host response to infection. Interestingly,
mRNA-seq analyses of these two factors suggest that they
may indirectly impact the overall cellular response to virus infec-
tion. However, it remains somewhat unclear how virus silencing
of these two factors provides the time necessary to influence the
host transcriptome in the context of a single round of infection.Cell Host & MWe speculate that loss of Mga or Zfx must rapidly diminish at
least one critical factor in the first 6–8 hr of infection that results
in the overall increase in virus titer. Such candidates include any
component of the IFN-I signaling cascade that would prevent
establishment of the antiviral state late in infection but could
also include a potent ISG.
Another interesting observation that derives from this in vivo
screen is the overall lack of ISGs identified. This may be due to
the inherent ability of the virus to already antagonize these fac-
tors through Nsp2 function, thereby biasing the results to non-
ISGs (Frolova et al., 2002). However, given that loss of specific
ISGs could confer a growth advantage in our in vitro screen,
this data may perhaps resonate the importance of some of the
more universal host genes in controlling virus levels. In this re-
gard, it would seem a successful strategy to enhance virus repli-
cation demands inducing a state of global cell deregulation. This
concept is in fact the basis of how oncolytic viruses are thought
tomediate replication specificity as transformation, by definition,
demands compromising the signaling networks of a primary cell
(Russell et al., 2012).
Despite the inherent limitations to this screen, the capacity to
identify host factors in the context of the actual infection is
invaluable. This screen permits bona fide virus replication as
the output, as opposed to surface staining or a reporter assay,
providing a more relevant and durable platform for identifying
host factors. In all, this screening strategy takes advantage of
multiple fundamental biological principles (RNAi, natural selec-
tion, and viral pathogenesis) to create a unique example of an
in vivo RNAi screen to identify virus/host interactions. It should
be noted that the knowledge obtained from this platform could
in no way be used to enhance the pathogenesis of a virus found
in nature. This is a result of the inherent attenuation that encoding
a hairpin incurs (Shapiro et al., 2010) and is presumably the
reason why RNA viruses do not naturally employ this strategy
(Cullen, 2011). However, generating a library of equally attenu-
ated viruses allows for selection of increased fitness only as it re-
lates to that population. Applying this technology to future
screens will undoubtedly identify factors responsible for virus
replication, tropism, transmission, or persistence and result in
a greater understanding of the interactions between virus and
host.EXPERIMENTAL PROCEDURES
Virus Design and Rescue
The SINV clones described were created by grafting hairpins, as described in
Supplemental Experimental Procedures, into the TE12Q clone, a genetically
modified strain containing a duplicate subgenomic mRNA promoter down-
stream of the structural genes (Cheng et al., 1996). MluI and NotI restriction
sites were added to a preexisting BsteII site, and In-Fusion PCR cloning (Clon-
tech Laboratories) was used to insert specified hairpins into SINV. The SINV
miR-30 library, which is described elsewhere (Silva et al., 2005), was cloned
into MluI and NotI via Infusion (Clontech) as per the manufacturer’s instruc-
tions. Plasmid DNA encoding the SINV miR-30 library was subsequently tran-
scribed using the mMessage mMachine SP6 Kit (Ambion), and 6 mg of RNA
was transfected into 6 3 106 BHK-21 cells using the Nucleofector II machine
(Lonza) and the Amaxa cell line Nucleofector Kit T reagent (Lonza). Rescued
virus was harvested 48 hr posttransfection and titered for future use. Barcoded
viruses were constructed by inserting 22 unique nucleotide barcodes into the
BsteII site in the subgenomic region of SINV. The barcoded library was
rescued and sequenced as described for the hairpin library. For in vitroicrobe 14, 346–356, September 11, 2013 ª2013 Elsevier Inc. 353
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serine substitution at position 726 of nsP2 to enhance IFN production (Frolova
et al., 2002). Rescue of these viruses were performed as described above.
Control viruses (SINV ctrl) were comprised of either a nonfunctional amiRNA
or miR-124, neither of which provides any growth advantage.
Cell Culture and Noninfectious Treatments
A549, Vero, BHK-21, Hepa 1.6, and murine embryonic fibroblast (MEF) cells
were cultured in DMEM media supplemented with 10% FBS and 1%
penicillin/streptomycin. RNA interference was performed using pools of oligo-
nucleotides designed to target nothing (scbl), Zfx, or Mga (Santa Cruz Biotech-
nologies, sc-37007 and sc-89945, respectively). Life Technologies’ silencer
select siRNAs targeting Polr1A-s223665, MUC5AC-s9074, EPRS- s4767,
RIG-I-s223614, and negative control #2-4390846 were used for SINV growth
advantage experiments. A total of 50 pmols of RNA oligonucleotide pools
were transfected into A549 and Hepa1.6 cells with Lipofectamine RNAiMAX
(Invitrogen). Conditional Dicer1 MEFs (Dcr1 fl/fl) (Harfe et al., 2005) or Zfx fibro-
blasts (Zfx fl/fl) (Galan-Caridad et al., 2007) were infected with adenovirus
expressing GFP or GFP-Cre (Vector Biolabs #1060 and #1700, respectively)
at a multiplicity of infection (moi) of 125 and treated 4 days postinfection as
described. IFN treatment was performed with recombinant universal IFNb
(R&D Systems) at a concentration of 100 units/ml. Transfection of the dsRNA
mimetic (polyI:C, Sigma) was performed using 5 mg of polyI:C with Lipofect-
amine 2000 (Invitrogen) on 10E6 cells. TNF-a (GIBCO) was used at a concen-
tration of 30 ng/ml. IFN and dsRNA treatments were performed at 10 hr and
TNF-a at 24 hr. Plasmid transfections were performed using 4 mg of plasmid
DNA with Lipofectamine 2000 (Invitrogen) on 10E6 cells and harvested 36–
72 hr posttransfection. Plasmids expressing amiRNAs, GFP, or Mga are
described elsewhere (Makeyev et al., 2007; Hurlin et al., 1999).
ISG Library
ISGs were selected based on previously published results (Schoggins et al.,
2011; tenOever et al., 2007). The NCBI sequence of each gene was entered
into http://biodev.extra.cea.fr/DSIR to generate 21 nt long siRNAs. The
siRNAs were then ranked selected based on previously published guidelines
for amiRNA design (Fellmann et al., 2011). The selected siRNA sequences
were inserted into themmu-miR-124-2 backbone, and SINVswere individually
rescued and titered. Viruses were combined at equal titers to construct the li-
brary. A miR-124-expressing virus was included as a negative control.
Virus Infections
Viral infections were performed at the moi specified in the text. IAV infections
were performed using the delta NS1 mutant previously described (Garcı´a-
Sastre et al., 1998). Virus was inoculated into indicated cell lines containing
serum-free DMEM for 1 hr for SINV or PBS supplemented with 0.3% BSA
(MP Biomedicals) and penicillin/streptomycin for IAV and collected at the
indicated times. Multicycle growth curves were performed with SINV recombi-
nants at indicated moi. A total of 0.1 ml of supernatant was removed at the
indicated times. Supernatant was plaqued in Vero cells in serial dilutions in
2% methylcellulose. Plaques were counted 3 days postinfection.
Animal Infections
C57BL/6 4-week-old female mice were purchased from Taconic. Mice were
anesthetized with 1:1:4.6 ketamine, xylazine, H2O mixture then infected via
footpad injection with 5 3 106 pfu, unless otherwise indicated. Spleens were
harvested 48 hr postinfection and homogenized with 500 ml of PBS for either
direct titering or propagation on BHK-21 cells and reinjection into mice for
passaging experiments. All experiments involving animals were performed in
accordance with Mount Sinai School of Medicine Institution of Animal Care
and Use Committee.
Deep Sequencing and Data analysis of Virus Libraries
For deep sequencing analysis of small RNAs derived from the SINV library,
samples were generated as previously described (Pfeffer et al., 2005). To
monitor viral populations, Superscript II (Invitrogen) was used with random
hexamers to generate cDNA, and then specific primers with barcoded Illumina
linkers were used to amplify the amiRNA hairpin region. Deep sequencing
samples were analyzed on the Illumina HiSeq 2000 sequencing platform. Us-354 Cell Host & Microbe 14, 346–356, September 11, 2013 ª2013 Eling various shell scripts, the amiRNA backbone was stripped and distinct
sequences were identified. Alignments were used to group sequences into
‘‘families’’ to control for sequencing error. These assigned IDs were kept
constant throughout samples. Custom scripts in both shell and Perl were
used to manage and analyze the data. A MySQL database was used to store
and process the raw data. Selection experiments were visualized using
Matlab. ISGs were defined as transcripts that increased by >2-fold according
to GEO: GSE6837. Characterized targets were identified by determining the
highest mean free energy (Mfe) targets to the predicted amiRNA, while
excluding bulges and G:U base pairing in the seed region. Remaining targets
were characterized en masse using highest Mfes as defined by RNAhybrid.
Virus populations within each passage were annotated using DAVID Bio-
informatics Resources as described (Huang da et al., 2009a, 2009b). Genes
enriched by 5-fold or greater, for which GO annotations existed, are listed
on Table S3.
mRNA-Seq Analysis
For mRNA-seq, mRNA was isolated from 1 mg of RNA using sera oligo-dT
beads. Isolated RNA was used for cDNA synthesis with SuperScript II reverse
transcriptase (Life Technologies). Samples then underwent second strand
synthesis, end-repair, A-tailing, ligation, and PCR using the Illumina Truseq
kit (Illumina, Cat. No1502062). Quality of amplified cDNA library was then
tested using the Bioanalyzer DNA 1000 Assay. mRNA-seq libraries were clus-
tered with cBOT (Illumina) and then run on HiSeq (Illumina) for 100 base single
read sequencing. Reads were analyzed using a pipeline based on Bowtie and
Samtools and aligned to the murine open reading frame database available
from Ensembl Biomart (http://www.ensembl.org/). Individual genes were
normalized as a percentage of total sample reads mapping to the reference
genome.
Small RNA Northern Blot Analysis
Small RNA northern blots and probe labeling were performed as previously
described (Pall and Hamilton, 2008). Probes used include: anti-miR-124, 50-
TGGCATTCACCGCGTGCCTTAA-30; GFP-480, 50-CGGCATCAAGGTGAAC
TTCAA-30; GFP-440, 50-ACAGCCACAACGTCTATATCA-30; GFP-417, 50-
GCACAAGCTGGAGTACAACTA-30; GFP-274, 50-GGCTACGTCCAGGAGCG
CACC-30; GFP-122, 50-TGCAAGCTGACCCTGAAGTTCA-30; RIG-I, 50-CT
CCCGGACTTCGAACACGTTA-30; amiRNA-USP32, 50-TGGTGACAACAG
TGGAAAGAAT-30; amiRNA-Zfx, 50-AGCCCACCTGGAGAGCCACAAA-30;
amiRNA-Mga, 50-AGCCATATCTCTGCAGATGAAA-30; amiRNA-ACAT1, 50-
CCCACTTTGAATGAAGTGGTTA-30; amiRNA-MORC4, 50-AGCAAAGGCTGC
TGAGAAGAAA-30; amiRNA-Pncr2, 50-AGCTAATTATTTCATTGGCAAA-30;
and anti-U6, 50-GCCATGCTAATCTTCTCTGTATC-30.
Western Blot Analysis
Western blots were generated from total protein separated on a 7.5%–10%
SDS-PAGE gel. Resolved protein was transferred to nitrocellulose (Bio-
Rad), blocked for 1 hr with 5% skim milk at 25C, and then incubated with
the indicated antibody overnight at 4C. Actin (Thermoscientific), Mga
(Abcam), SINV Capsid (a kind gift from Dr. D. Griffin, Johns Hopkins),
STAT1-C111 (Santa Cruz), RIG-I (a kind gift from Dr. A. Garcia-Sastre,
MSSM), Zfx polyclonal (a kind gift from Dr. Boris Reizis), and the PR8 poly-
clonal antibody (a kind gift from Dr. P. Palese, MSSM) antibodies were all
used at a concentration of 1 mg/ml in 5% skim milk. Secondary mouse and
rabbit antibodies (GE Healthcare) were used at a 1:5,000 dilution for 1 hr at
25C. Immobilon Western Chemiluminescent HRP Substrate (Millipore) was
used as directed.
Statistical Analysis
All plaque assays and growth curves were determined in three biological
replicates and plaqued in two technical replicates unless otherwise indicated.
One-tailed Student’s t tests were performed on biological replicates to deter-
mine significance unless otherwise indicated. Luciferase assays were
performed in three biological replicates. One-tailed Student’s t tests were per-
formed on biological replicates to determine significance. qPCR analysis was
performed in two biological replicates and analyzed in two technical replicates
unless otherwise indicated. One-tailed Student’s t tests were performed on
biological replicates to determine significance.sevier Inc.
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Conventional qPCR was performed on indicated cDNA samples using KAPA
SYBR FAST qPCR Master Mix (KAPA biosystems). Delta delta cycle thresh-
olds were calculated using tubulin as the endogenous housekeeping gene
and mock treated cells as the calibrator in respective experiments. Primers
used include: mRIG-I, 50- AAGAGCCAGAGTGTCAGAATCT-30 and 50-
AGCTCCAGTTGGTAATTTCTTGG-30; hStat1, 50-CTTCTCTGGCGACAGT
TTTC-30 and 50-CCTTTCAATTTTACCTTCAG-30; hactin, 50-ACTGGAACGGT
GAAGGTGAC-30 and 50-GTGGACTTGGGAGAGGACTG-30; ma-tubulin, 50-
TGCCTTTGTGCACTGGTATG-30 and 50-CTGGAGCAGTTTGACGACAC-30;
hMmp-9, 50-CTTTGAGTCCGGTGGACGAT-30 and 50-TCGCCAGTACTTCC
CATCCT-30; hZfx, 50-TTGCTGAAATCGCTGACGAAG-30 and 50-GCAATCGG
CATGAAGGTTTTGAT-30; mZfx, 50- GCAGTGCATGAACAGCAAGT-30 and 50-
GCAAGGTGTTCAGGATGGTT-30; hMga, 50- AGGAGCACGTGGACATTGAG-
30 and 50-TTGGTGGAGCCTTTCGACTC-30; mMga, 50- GGCCAATTGAA
AATGCCCCT-30 and 50-GTAGGAGAACCCTGCTGCAC-30; hIFNb, 50-GTCA
GAGTGGAAATCCTAAG-30 and 50-ACAGCATCTGCTGGTTGAAG-30.
Luciferase Assay
BHKs were transfected with Gaussian luciferase constructs containing the
indicated target sites, untargeted firefly luciferase, and a plasmid expressing
the indicated hairpin. Where applicable, BHKswere infected 2 hr posttransfec-
tion at an moi of three. Twelve hours posttransfection or 18 hr postinfection,
mediumwas replaced with serum-free DMEM. Four hours after media change,
luciferase expression was determined as per the manufacturer’s instructions
(Promega), with levels normalized to firefly luciferase and the untargeted
control.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, four tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.chom.2013.08.007.
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